Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NGS platforms such as PacBio for applications including structural variants, HLA typing and repeat expansions QIAGEN supporting fully integrated workflow from best-in-class sample preparation through to powerful bioinformatics for analysis and interpretation VENLO, The Netherlands — […]
As the global leader in automated patch clamping technology, we proudly announce the launch of Ethica M, our next-generation high throughput organ-on-a-chip contractility solution. Building on more than 25 years of scientific and engineering excellence in high-throughput electrophysiology, we now enter the emerging field of microphysiological systems with an automated and standardized platform for human-relevant […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial Officer of the Company’s Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher’s Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, […]
Seasoned Executive with Proven Track Record of Value Creation in Life Sciences RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025. […]
IRVINE, Calif. – Zymo Research, a leader in biotechnology innovation, announces the launch of Endura™ Tn5 Transposase, a next-generation advancement in Tn5-based technologies for next-generation sequencing (NGS) library preparation. “Endura™ has been specifically developed for unprecedented stability and consistent performance in NGS-based applications”, said Dr. Joshua Misa, R&D Scientist at Zymo Research. Since the development […]
REDWOOD CITY, Calif. — Synthego, a leading provider of CRISPR solutions, today announced the successful closing of the acquisition of substantially all of its assets by funds managed by Perceptive Advisors, a leading life sciences investment firm. The transaction officially closed on July 18, 2025. Under the new ownership of the Perceptive funds, Synthego will […]
ZEISS Group recently announced that Martin Fischer will officially take on the role of President and CEO of ZEISS Greater China, effective from October 1, 2025, reporting directly to Andreas Pecher, President and CEO of the ZEISS Group. Martin Fischer succeeds Maximilian Foerst, who joined the Executive Board of the ZEISS Group as the President […]
Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board members Q2 ’25 revenue anticipated to be $20.4 million and Company reiterates previously announced Q2 ‘25 gross margin guidance HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today […]
MADISON, Wis. — BrainXell, a leading producer of iPSC-derived human neurons and glia, is proud to announce the continued growth of its executive leadership team with the appointment of Paul Marcus as President, Chief Operating Officer, Chief Financial Officer and Board of Directors. Paul Marcus, BrainXell President, COO & CFO The company also continues to […]
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases PLEASANTON, Calif. and SINGAPORE — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), today announced a research collaboration for the Target […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
